Famotidine
This article was originally published in The Tan Sheet
Executive Summary
FDA approves ANDA 75-512 for Ivax' generic equivalent to J&J/Merck's Pepcid AC July 26, Miami-based company reports. Ivax famotidine 10 mg is first to carry heartburn prevention claim. Teva Pharmaceuticals received ANDA approval for a heartburn treatment claim May 31, according to FDA; firm licenses its version to Perrigo for sale in U.S. (1"The Tan Sheet" June 4, p. 7). Cheminor Drugs and Danbury Pharmacal have received tentative approval
You may also be interested in...
Perrigo Famotidine Approved With Six Month Exclusivity; Shipments Begin
Perrigo's private label famotidine 10 mg was approved by FDA May 31, ending a drawn out delay of the generic launch.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands